Goddard M J, Wilson B, Grant J W
Department of Histopathology, Addenbrooke's Hospital, Cambridge.
J Clin Pathol. 1991 Aug;44(8):660-3. doi: 10.1136/jcp.44.8.660.
Five commercially available cytokeratin antibodies (lu-5, AE1/AE3, CAM 5.2, MFN116 and anti-cytokeratin 18) were used to stain a wide range of normal and neoplastic epithelial and non-epithelial tissues to assess their potential value in diagnostic histopathology. All five showed good specificity, with some cross-reactivity in smooth muscle cells. The wider reactivity of AE1/AE3, lu-5, and MFN 116, which includes cytokeratins 8,18 (Moll's catalogue) expressed in simple epithelia and their tumours, as well as cytokeratins expressed in complex stratified squamous epithelia, permits identification of a wider range of epithelial derived tumours. This wider spectrum of reactivity may allow these antibodies to be used in a diagnostic panel for the identification of poorly differentiated tumours.
使用五种市售的细胞角蛋白抗体(lu-5、AE1/AE3、CAM 5.2、MFN116和抗细胞角蛋白18)对多种正常和肿瘤性上皮及非上皮组织进行染色,以评估它们在诊断组织病理学中的潜在价值。所有五种抗体均表现出良好的特异性,在平滑肌细胞中有一些交叉反应性。AE1/AE3、lu-5和MFN 116具有更广泛的反应性,包括在单层上皮及其肿瘤中表达的细胞角蛋白8、18(莫尔分类),以及在复层鳞状上皮中表达的细胞角蛋白,这使得能够识别更广泛的上皮源性肿瘤。这种更广泛的反应谱可能使这些抗体可用于诊断组合,以识别低分化肿瘤。